Date Filed | Type | Description |
06/08/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
05/24/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,190 shares
@ $0 |
|
05/19/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
02/27/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Exercised 136 restricted stock units
@ $0 |
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2021 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
07/01/2021 |
4/A
| PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
06/30/2021 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/29/2020 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,300 shares
@ $0 |
|
04/24/2020 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Exercised 1,414 shares
@ $107.56, valued at
$152.1k
Exercised 1,414 options to buy
@ $0 |
|
02/05/2020 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Sold 5,027 shares
@ $132.72, valued at
$667.2k
Exercised 5,027 options to buy
@ $38.18, valued at
$191.9k
|
|
07/02/2019 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
06/06/2019 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,430 shares
@ $0 |
|
05/02/2019 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Exercised 641 shares
@ $109.63, valued at
$70.3k
Exercised 1,336 shares
@ $109.63, valued at
$146.5k
Exercised 641 options to buy
@ $0 Exercised 1,336 options to buy
@ $0 Granted 1,414 options to buy
@ $0 |
|
11/28/2018 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Sold 2,000 shares
@ $93, valued at
$186k
Exercised 2,000 options to buy
@ $20.64, valued at
$41.3k
|
|
06/22/2018 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
06/07/2018 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,300 shares
@ $0 |
|
05/02/2018 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Exercised 747 shares
@ $104.8, valued at
$78.3k
Exercised 641 shares
@ $104.8, valued at
$67.2k
Exercised 1,678 shares
@ $104.8, valued at
$175.9k
Exercised 747 options to buy
@ $0 Exercised 641 options to buy
@ $0 Exercised 1,678 options to buy
@ $0 Granted 1,336 options to buy
@ $0 |
|
08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/09/2016 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on Avery Dennison Corp
Txns:
| Sold 2,000 shares
@ $78.61, valued at
$157.2k
Exercised 2,000 options to buy
@ $67.795, valued at
$135.6k
|
|
06/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|